​

SOPHiA GENETICS SA (SOPH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

SOPH Stock Forecast

SOPHiA GENETICS SA (SOPH) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $5.00, with a high of $5.00 and a low of $5.00. This represents a 76.68% increase from the last price of $2.83.

High: $5 Avg: $5 Low: $5 Last Closed Price: $2.83

SOPH Stock Rating

SOPHiA GENETICS SA stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (83.33%), 1 Hold (16.67%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 1 5 0 Strong Sell Sell Hold Buy Strong Buy

SOPH Price Target Upside V Benchmarks

TypeNameUpside
StockSOPHiA GENETICS SA76.68%
SectorHealthcare Stocks 35.25%
IndustryHealthcare Information Services Stocks 36.10%

Price Target Trends

1M3M12M
# Anlaysts-13
Avg Price Target-$5.00$5.33
Last Closing Price$2.83$2.83$2.83
Upside/Downside-76.68%88.34%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25141--6
Mar, 25141--6
Feb, 25141--6
Jan, 25141--6
Dec, 24141--6
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 06, 2025BTIG$5.00$3.1160.77%76.68%
Aug 07, 2024Tejas SavantMorgan Stanley$5.00$3.9227.55%76.68%
Jun 27, 2024Subbu NambiGuggenheim$6.00$4.5232.74%112.01%
Jan 03, 2023Mark MassaroBTIG$6.00$2.06191.26%112.01%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 18, 2024Craig-HallumBuyinitialise
Sep 11, 2024Cowen & Co.BuyBuyhold
Aug 07, 2024Morgan StanleyEqual-Weightdowngrade
Aug 07, 2024Morgan StanleyPositivedowngrade
Jun 27, 2024GuggenheimBuyinitialise
May 28, 2024BTIGBuyBuyhold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.33$-1.36$-1.22-----
Avg Forecast$-1.34$-1.43$-0.99$-0.89$-0.79$-0.60$-0.54$-0.45
High Forecast$-1.29$-1.37$-0.96$-0.85$-0.76$-0.49$-0.52$-0.43
Low Forecast$-1.36$-1.47$-1.04$-0.93$-0.82$-0.69$-0.57$-0.47
Surprise %-0.75%-4.90%23.23%-----

Revenue Forecast

$35M $54M $73M $92M $111M $130M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$40.45M$47.56M$62.37M-----
Avg Forecast$40.89M$47.05M$62.49M$65.14M$74.51M$93.98M$118.25M$121.90M
High Forecast$41.50M$48.31M$62.50M$65.17M$74.98M$94.84M$122.67M$126.45M
Low Forecast$39.70M$45.58M$62.47M$65.10M$74.05M$93.12M$114.82M$118.37M
Surprise %-1.08%1.08%-0.20%-----

Net Income Forecast

$-100M $-85M $-70M $-55M $-40M $-25M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-73.67M$-87.45M$-78.98M-----
Avg Forecast$-86.55M$-92.29M$-64.61M$-57.72M$-51.21M$-44.38M$-35.16M$-29.14M
High Forecast$-83.26M$-88.54M$-61.84M$-55.25M$-49.02M$-31.77M$-33.65M$-28.04M
Low Forecast$-88.22M$-95.50M$-67.38M$-60.20M$-53.41M$-44.95M$-36.66M$-30.55M
Surprise %-14.88%-5.24%22.23%-----

SOPH Forecast FAQ

Is SOPHiA GENETICS SA stock a buy?

SOPHiA GENETICS SA stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that SOPHiA GENETICS SA is a favorable investment for most analysts.

What is SOPHiA GENETICS SA's price target?

SOPHiA GENETICS SA's price target, set by 6 Wall Street analysts, averages $5 over the next 12 months. The price target range spans from $5 at the low end to $5 at the high end, suggesting a potential 76.68% change from the previous closing price of $2.83.

How does SOPHiA GENETICS SA stock forecast compare to its benchmarks?

SOPHiA GENETICS SA's stock forecast shows a 76.68% upside, outperforming the average forecast for the healthcare stocks sector (35.25%) and outperforming the healthcare information services stocks industry (36.10%).

What is the breakdown of analyst ratings for SOPHiA GENETICS SA over the past three months?

  • April 2025: 16.67% Strong Buy, 66.67% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 16.67% Strong Buy, 66.67% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 16.67% Strong Buy, 66.67% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.

What is SOPHiA GENETICS SA’s EPS forecast?

SOPHiA GENETICS SA's average annual EPS forecast for its fiscal year ending in December 2024 is $-0.89, marking a -27.05% decrease from the reported $-1.22 in 2023. Estimates for the following years are $-0.79 in 2025, $-0.6 in 2026, $-0.54 in 2027, and $-0.45 in 2028.

What is SOPHiA GENETICS SA’s revenue forecast?

SOPHiA GENETICS SA's average annual revenue forecast for its fiscal year ending in December 2024 is $65.14M, reflecting a 4.44% increase from the reported $62.37M in 2023. The forecast for 2025 is $74.51M, followed by $93.98M for 2026, $118.25M for 2027, and $121.9M for 2028.

What is SOPHiA GENETICS SA’s net income forecast?

SOPHiA GENETICS SA's net income forecast for the fiscal year ending in December 2024 stands at $-57.725M, representing a -26.91% decrease from the reported $-78.981M in 2023. Projections indicate $-51.215M in 2025, $-44.379M in 2026, $-35.156M in 2027, and $-29.138M in 2028.